Fresenius Medical Care Beteiligungsgesellschaft mbH Sustainability Profile
Fresenius Medical Care Beteiligungsgesellschaft mbH, commonly referred to as Fresenius Medical Care, is a leading global provider of products and services for individuals undergoing dialysis. Headquartered in Germany, the company operates extensively across Europe, North America, and Asia, solidifying its presence in the healthcare industry. Founded in 1996, Fresenius Medical Care has achieved significant milestones, including the development of innovative dialysis technologies and comprehensive care solutions. The company’s core offerings include dialysis machines, dialysers, and a range of related services, distinguished by their commitment to quality and patient-centric care. With a strong market position, Fresenius Medical Care is recognised for its extensive network of dialysis clinics and its dedication to improving patient outcomes, making it a pivotal player in the renal care sector.
DitchCarbon Score
How does Fresenius Medical Care Beteiligungsgesellschaft mbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Fresenius Medical Care Beteiligungsgesellschaft mbH's score of 33 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Fresenius Medical Care Beteiligungsgesellschaft mbH, headquartered in Germany, currently does not report specific carbon emissions data for the most recent year, as no emissions figures are available. The company is a current subsidiary of Fresenius Medical Care AG, which may influence its climate commitments and performance metrics. While there are no documented reduction targets or climate pledges specific to Fresenius Medical Care Beteiligungsgesellschaft mbH, it is important to note that any relevant initiatives or targets may be inherited from its parent company, Fresenius Medical Care AG. This includes potential commitments to the Science Based Targets initiative (SBTi) and participation in the Carbon Disclosure Project (CDP), both of which are cascaded from the parent organisation. As a part of the healthcare sector, Fresenius Medical Care Beteiligungsgesellschaft mbH is positioned within an industry increasingly focused on sustainability and reducing carbon footprints. However, without specific emissions data or reduction targets, the company's current climate impact remains unclear.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000.0 |
| Scope 2 | 557,200,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | 0,000,000,000 | 0,000.0 |
How Carbon Intensive is Fresenius Medical Care Beteiligungsgesellschaft mbH's Industry?
How Carbon Intensive is Fresenius Medical Care Beteiligungsgesellschaft mbH's Location?
Fresenius Medical Care Beteiligungsgesellschaft mbH's Scope 3 Categories Breakdown
Fresenius Medical Care Beteiligungsgesellschaft mbH's Scope 3 emissions, which decreased by 100% last year and decreased by approximately 100% since 2023, demonstrating supply chain emissions tracking. Their carbon footprint includes supplier sustainability and value chain emissions data across Scope 3 categories, with "Purchased Goods and Services" being the largest emissions source at 17640922% of Scope 3 emissions.
Top Scope 3 Categories
Fresenius Medical Care Beteiligungsgesellschaft mbH's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Fresenius Medical Care Beteiligungsgesellschaft mbH has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.